Regard AI Clinical Insights Platform
Proactive Documentation to transform care
Company profile
Company profile
Regard is a healthcare AI company that transforms clinical documentation through its AI-powered Clinical Insights Platform. The company addresses a critical gap in healthcare: with single patient records containing an average of 50,000 data points, clinicians can only review approximately 3% of patient data at the point of care. Regard's innovative approach shifts from reactive to proactive documentation by unifying clinical and administrative teams through AI-generated, near-complete and accurate documentation created before physicians see patients. The platform reviews all data in patient charts to recommend diagnoses and generate complete documentation at the point of care. This "Proactive Documentation" approach enhances quality of care by surfacing critical insights in patients' medical histories, ensuring undiagnosed conditions, vital context, and medications are no longer missed. The platform has achieved over 1 million recommended diagnoses accepted by clinicians. Regard serves health systems and hospitals, helping them improve patient safety, reduce physician documentation burden, and unlock revenue through more complete and accurate clinical documentation. The company has demonstrated significant impact with clients reporting millions in revenue increases and substantial time savings for clinicians.
Company description Regard official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Cloud Saas deployment with recorded integration context.
Company milestones
Surpassed 1 million recommended diagnoses accepted by clinicians. Multiple health system implementations with documented revenue and efficiency improvements.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Proactive Documentation to transform care
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
The British journal of educational psychology · Aug 19, 2026
Hypnogram-derived structured data reveal differences in sleep stage transition characteristics between high and low arousal threshold patients.Sleep medicine · Jul 1, 2026
Satisfaction With Youth Mental Health Services in Diverse Settings: Results From a Pan-Canadian Initiative.Psychiatric services (Washington, D.C.) · Jun 1, 2026
Classification and regression trees to identify COPD subgroups in clinical trial populations: insights from the IMPACT trial.BMC pulmonary medicine · May 19, 2026
Difficult-to-treat COPD: from concept to practice.Presse medicale (Paris, France : 1983) · Mar 1, 2026
Palliative care follow-up for cancer patients combining day-hospital visits and telemedicine: What feasibility?PloS one · Jan 1, 2026
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
clinician acceptance rate
Penn Highlands case study
Penn Highlands case study
Sentara Health case study
Sentara Health case study
Enhance accuracy of patient records and medical history documentation
Enhanced precision and efficiency in patient record accuracy
Increase patient safety, enhance documentation, and reduce physician burden
Significant offloading of physician burden while increasing patient safety
Revenue capture and time savings through proactive documentation
$7M revenue increase and 30% time savings
Improve patient safety and protect revenue with proactive documentation
Improved patient safety and protected revenue
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on Regard's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
Geographic disparities and insurance gaps leave millions of American women facing both life-threatening care deserts and thousands in out-of-pocket childbirth costs despite living in the world's wealthiest nation.
Health Equity & Access · Jul 2, 2026
Analysis of 2.3 million veterans reveals the updated vaccine formulation may offer unexpected cardiovascular protection alongside infection prevention benefits.
Clinical AI · Jun 26, 2026
FDA's new guidance on Bayesian statistical methods opens the door to adaptive clinical trials that could accelerate drug development while reducing costs and patient exposure to ineffective treatments.
Policy & Regulation · Jun 18, 2026
FDA's new guidance on Bayesian statistical methods opens the door to adaptive clinical trials that could accelerate drug development while reducing costs and patient exposure to ineffective treatments.
Policy & Regulation · Jun 17, 2026
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that use AI to automate clinical documentation, generate medical notes from patient-clinician conversations, or streamline clinical workflows. Includes ambient AI scribes, voice-to-text medical documentation, NLP-powered clinical note generation, and tools that reduce administrative burden on clinicians.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.